TY  - JOUR
T1  - An Overview on Diagnosis and Management of Non-alcoholic Fatty Liver Disease
A1  - Abdalrahman Fadulalseed Wedaatella
A1  - Rahaf Abdulrahman Almehery
A1  - Ranaa Mohammed Al Namar
A1  - Aishah Saeed M Shmashir
A1  - Amro Musa Alam Alhouda
A1  - Anas Ameen Fallatah
A1  - Ali Abdalla Ali Osman
A1  - Noor Hassan A Alazmi
A1  - Mohammed Ahmed M Hurubi
A1  - Zainab Abdullah Al Khuraidah
A1  - Esraa Ahmed Akili
JF  - International Journal of Pharmaceutical Research and Allied Sciences
JO  - Int J Pharm Res Allied Sci
SN  - 2277-3657
Y1  - 2021
VL  - 10
IS  - 2
DO  - 10.51847/QKKcVYgTBX
SP  - 144
EP  - 148
N2  - Non-alcoholic fatty liver disease (NAFLD) is difficult to define, has intricate pathogenesis, has a high outbreak, and few acquiesced treatments are available. Thus, this condition has posed a great challenge in our time. The non-alcoholic fatty liver disorder is correlated with obesity and insulin resistance and is emerging as the most ordinary form of chronic liver disorder in grown-ups and kids alike. The Pubmed, NCBI, Medline, Cochrane databases, and Embase were searched for patients' studies with nonalcoholic fatty liver disorder. Management options, Incidence, and causes were all investigated. NAFLD is a quickly rising reason for a chronic liver disorder. It is a complicated condition that encounters multiple challenges in its management and assessment. If it's not treated on time, hepatic steatosis may progress to NASH and eventually liver cirrhosis. Controlling this illness requires a multidisciplinary technique. We hope that treatment options for advanced stages of the condition will meliorate in the next decade. 
UR  - https://ijpras.com/article/an-overview-on-diagnosis-and-management-of-non-alcoholic-fatty-liver-disease-anwk0m7kkcuzsrl
ER  -